trial

A Neurofeedback Intervention to Improve Working Memory in Schizophrenia

NCTId NCT03260257
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
— · Completed
Enrollment 64 (actual)
Sponsored by University of California Riverside at C.I. Trials, Inc.-Inland Empire
Primary completion 2024-04-01
Synthesized from structured facts only — each point cited above.

Design & status

Phase
—
Status
Completed
Enrollment
64 (actual)
Study type
Interventional
Allocation
Na
Model
Parallel
Masking
None
Start
2018-03-01
Primary completion
2024-04-01
Eligibility
ALL · 18 Years · 65 Years

Interventions & indications

Drugs
Neurofeedback

Sponsors

University of California Riverside at C.I. Trials, Inc.-Inland EmpireLead Sponsor
National Institutes of Health (NIH)Collaborator

Sites

1 total
La Jolla, United States

Facts & assertions

4 sourced
Enrollment
64
Phase
NA
Primary Completion Date
2024-04-01
Status
COMPLETED
relationships
The graph out of here
drug
Neurofeedback
drug
lead_sponsor
University of California Riverside at C.I. Trials, Inc.-Inland Empire
company
collaborator
National Institutes of Health (NIH)
company
indication
Schizophrenia
indication
Schizophrenia
indication